Skip to main content

Table 5 Anchor-based MCID and ROC estimates for RS-SC at 3-month (T1, N = 643)

From: Minimum clinical important difference for resilience scale specific to cancer: a prospective analysis

Indicators Scale Anchors Mean change (95%CI) Effect Size Cut-off Sen Spe YI AUC P
aImprovement RS-SC-10 QoL GHS 3.62 (3.34 to 3.91) 0.48 2.00 0.62 0.69 0.31 0.68 < 0.001
CD-RISC-10 3.29 (3.10 to 3.48) 0.41 2.00 0.71 0.69 0.40 0.73 < 0.001
HADS-A 3.05 (2.79 to 3.20) 0.40 2.00 0.61 0.66 0.27 0.67 < 0.001
HADS-D 3.42 (3.18 to 3.66) 0.44 2.00 0.69 0.64 0.33 0.69 < 0.001
RS-SC-25 QoL GHS 9.31 (8.83 to 9.81) 0.51 5.50 0.58 0.67 0.25 0.65 < 0.001
CD-RISC-10 8.56 (8.23 to 8.91) 0.41 5.50 0.72 0.65 0.37 0.70 < 0.001
HADS-A 8.78 (8.29 to 9.29) 0.44 5.50 0.59 0.67 0.26 0.66 < 0.001
HADS-D 8.97 (8.50 to 9.44) 0.48 5.50 0.70 0.61 0.31 0.68 < 0.001
bDeterioration RS-SC-10 QoL GHS − 2.59 (− 2.79 to − 2.39) − 0.35 − 1.50 0.64 0.68 0.32 0.69 < 0.001
CD-RISC-10 − 2.26 (− 2.39 to − 2.14) − 0.28 − 1.50 0.71 0.71 0.42 0.74 < 0.001
HADS-A − 2.61 (− 2.77 to − 2.43) − 0.34 − 1.50 0.60 0.66 0.26 0.66 < 0.001
HADS-D − 2.48 (− 2.65 to − 2.32) − 0.32 − 1.50 0.74 0.67 0.41 0.72 < 0.001
RS-SC-25 QoL GHS − 6.81 (− 7.18 to − 6.42) − 0.37 − 4.50 0.61 0.68 0.29 0.68 < 0.001
CD-RISC-10 − 6.19 (− 6.64 to − 5.93) − 0.29 − 4.50 0.72 0.69 0.41 0.73 < 0.001
HADS-A − 7.05 (− 7.39 to − 6.70) − 0.36 − 4.50 0.59 0.68 0.27 0.66 < 0.001
HADS-D − 6.79 (− 7.11 to 6.47) − 0.36 − 4.50 0.72 0.64 0.36 0.70 < 0.001
  1. Sen Sensitivity, Spe Specificity, YI Youden Index, AUC area under curve or C-statistic
  2. a Improvement was defined for QoL GHS (raw score, increased by 1 point), CD-RISC-10 (increased by 3 points), HADS-A (decreased by 1.5 points) and HADS-D (decreased by 1.5 points)
  3. b Deterioration was defined for QoL GHS (raw score, decreased by 1 point in global health status), CD-RISC-10 (decreased by 3 points), HADS-A (increased by 1.5 points) and HADS-D (increased by 1.5 points)